About

Mingham Ji is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Anti-Corruption practice groups.

Mingham Ji is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Anti-Corruption practice groups. Ms. Ji advises food, dietary supplement, pharmaceutical, and biotechnology companies on regulatory and compliance issues.

3 Takeaways Digital Health Innovators Should Be Watching in the PREVENT Pandemics Act

February 23, 2022

5 Digital Health Issues to Watch at FDA in 2022

January 6, 2022

Reps. DeGette and Upton Release Highly-Anticipated “Cures 2.0” Draft

June 24, 2021

FDA Announces Public Workshop on Using Randomized Clinical Trials to Generate Real-World Evidence

June 10, 2019

Significant FDA Digital Health Policy Development for Prescription Drug Sponsors

December 4, 2018

FDA Finalizes General Wellness Guidance

August 5, 2016

About

Mingham Ji is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Anti-Corruption practice groups.

Mingham Ji is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Anti-Corruption practice groups. Ms. Ji advises food, dietary supplement, pharmaceutical, and biotechnology companies on regulatory and compliance issues.

Connect:

Subscribe:

Blogs

Covington Digital Health

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website. To exercise your right to opt-out of the sale or sharing of your personal information for targeted advertising purposes, click “reject.” Privacy Policy